Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Protalix BioTherapeutics Inc.    PLX

Delayed Quote. Delayed  - 05/27 09:58:42 pm
0.791 USD   +1.02%
05/09 PROTALIX BIOTHE : reports 1Q loss
05/09 Protalix BioTherapeutics Reports First Quarter 2016 Financial Res..
03/08 Protalix BioTherapeutics Reports Fiscal Year 2015 Financial Resul..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
0.8(c) 0.8002(c) 0.79(c) 0.783(c) 0.791(c) Last
84 679 57 611 41 643 50 173 32 924 Volume
0.00% +0.02% -1.27% -0.89% +1.02% Change
More quotes
Financials ($)
Sales 2013 15,8 M
EBIT 2013 -19,9 M
Net income 2013 -19,0 M
Debt 2013 -
Yield 2013 -
Sales 2014 35,8 M
EBIT 2014 -12,9 M
Net income 2014 -4,70 M
Debt 2014 -
Yield 2014 -
P/E ratio 2013 -
P/E ratio 2014
Capi. / Sales 2013 5,01x
Capi. / Sales 2014 2,21x
Capitalization 78,9 M
More Financials
Company
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system.It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease.Its drug... 
More about the company
Surperformance© ratings of Protalix BioTherapeutics I
Trading Rating : Investor Rating :
More Ratings
Latest news on PROTALIX BIOTHERAPEUTICS I
05/09 PROTALIX BIOTHERAPEUTICS : reports 1Q loss
05/09 PROTALIX BIOTHERAPEUTICS, INC. : Results of Operations and Financial Condition (..
05/09 Protalix BioTherapeutics Reports First Quarter 2016 Financial Results and Pro..
04/08 PROTALIX BIOTHERAPEUTICS : Other Events (form 8-K)
04/01 PROTALIX BIOTHERAPEUTICS : Amendments to Articles of Inc. or Bylaws; Change in F..
03/08 PROTALIX BIOTHERAPEUTICS : Results of Operations and Financial Condition (form 8..
03/08 Protalix BioTherapeutics Reports Fiscal Year 2015 Financial Results and Provi..
03/03 PROTALIX BIOTHERAPEUTICS : Other Events, Financial Statements and Exhibits (form..
03/03 Protalix BioTherapeutics Presents Positive Six and Twelve Month Interim Clini..
02/22 Protalix BioTherapeutics to Participate in the SunTrust Robinson Humphrey Orp..
More news
Sector news : Biotechnology & Medical Research - NEC
09:07a Samsung Bioepis receives final European approval for its Remicade copy
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart PROTALIX BIOTHERAPEUTICS I
Duration : Period :
Protalix BioTherapeutics I Technical Analysis Chart | PLX | US74365A1016 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions